Clinical Trials List
2022-04-01 - 2026-12-31
Phase II
Recruiting7
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Pin Li 無
- Chien-An Liu 無
- Yun-Cheng Hsieh 無
- Yi-Ping Hung 無
- 姜乃榕 無
- Yee Chao 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳峯旭 無
- YI-JU CHEN 無
- YU-HSUAN SHIH 無
- HSIN-CHEN LIN 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang 無
- 高育青 無
- 蘇勇曄 Division of Hematology & Oncology
- Li-Tzong Chen 無
- Jeng-Shiun Du 無
- Tsung-Jang Yeh 無
- Wang Yao-Kuang 無
- Yi-Hsun Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐執中 無
- Wen-Chi Shen 無
- 陳建銘 無
- 黃文冠 無
- 余紹銘 無
- Jen-Shi Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王秀慈 無
- 邱昌芬 無
- Che-Hung Lin 無
- Chang-Fang Chiu 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
